Figure 14 is a metagraph depicting the effect of risperidone on VAS for symptom improvement in disruptive behavior disorders. Three studies with 560 patients were available but they were not pooled due to substantial heterogeneity. All trials showed a significantly greater improvement in symptoms for risperidone compared with placebo.

Figure 14Risperidone versus placebo on VAS in disruptive behavior disorders

CI = confidence interval; DBD = disruptive behavior disorders; IV = inverse variance; SD = standard deviation; SGA = second-generation antipsychotic; VAS = visual analogue scale

From: Results

Cover of First- and Second-Generation Antipsychotics for Children and Young Adults
First- and Second-Generation Antipsychotics for Children and Young Adults [Internet].
Comparative Effectiveness Reviews, No. 39.
Seida JC, Schouten JR, Mousavi SS, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.